Correction To: CBFA2T2 is Associated with a Cancer Stem Cell State in Renal Cell Carcinoma

Du-Chu Chen,You-De Liang,Liang Peng,Yi-Ze Wang,Chun-Zhi Ai,Xin-Xing Zhu,Ya-Wei Yan,Yasmeen Saeed,Bin Yu,Jingying Huang,Yuxin Gao,Jiaqi Liu,Yi-Zhou Jiang,Min Liu,Demeng Chen

DOI: https://doi.org/10.1186/s12935-018-0564-5

IF: 6.429

2018-01-01

Cancer Cell International

Abstract:[This corrects the article DOI: 10.1186/s12935-017-0473-z.].

What problem does this paper attempt to address?

Correction: the Combination Effect of Homoharringtonine and Ibrutinib on FLT3-ITD Mutant Acute Myeloid Leukemia

Xia Li,Xiufeng Yin,Huafeng Wang,Jiansong Huang,Mengxia Yu,Zhixin Ma,Chenying Li,Yile Zhou,Xiao Yan,ShuJuan Huang,Jie Jin

DOI: https://doi.org/10.18632/oncotarget.27310

2019-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.14463.].
CBFA2T2 is associated with a cancer stem cell state in renal cell carcinoma

Du-Chu Chen,You-De Liang,Liang Peng,Yi-Ze Wang,Chun-Zhi Ai,Xin-Xing Zhu,Ya-Wei Yan,Yasmeen Saeed,Bin Yu,Jingying Huang,Yuxin Gao,Jiaqi Liu,Yi-Zhou Jiang,Min Liu,Demeng Chen

DOI: https://doi.org/10.1186/s12935-017-0473-z

IF: 6.429

2017-01-01

Cancer Cell International

Abstract:Renal cell carcinoma (RCC) is the most common kidney cancer, accounting for approximately 80–90% of all primary kidney cancer. Treatment for patients with advanced RCC remains unsatisfactory. Rare cancer stem cells (CSCs) are proposed to be responsible for failure of current treatment.
Correction To: Cancer Biother Radiopharm 2017;32(3):101–110

Wang Bi,Zhi Huang,Rui Gao,Zhu Zeng,Weiming Yang,Yan Sun,Wei,Zhongqing Wu,Lei Yu,Qinshan Li,Shuai Zhang,Fenghu Li,Guoli Li,Bingjie Liu,Li Leng,Wei Zhan,Yu Yang,Guozhen Yang,Shi Zhou

DOI: https://doi.org/10.1089/cbr.2016.2156.correx

2017-01-01

Cancer Biotherapy & Radiopharmaceuticals

Abstract:Cancer Biotherapy & RadiopharmaceuticalsVol. 32, No. 4 CorrectionCorrection to: Cancer Biother Radiopharm 2017;32(3):101–110Published Online:1 May 2017https://doi.org/10.1089/cbr.2016.2156.correxAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"Correction to: Cancer Biother Radiopharm 2017;32(3):101–110." Cancer Biotherapy and Radiopharmaceuticals, 32(4), p. 147FiguresReferencesRelatedDetails Volume 32Issue 4May 2017 InformationCopyright 2017, Mary Ann Liebert, Inc.To cite this article:Correction to: Cancer Biother Radiopharm 2017;32(3):101–110.Cancer Biotherapy and Radiopharmaceuticals.May 2017.147-147.http://doi.org/10.1089/cbr.2016.2156.correxOnline Ahead of Print:May 5, 2017Published in Volume: 32 Issue 4: May 1, 2017PDF download
CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis: Erratum

Wenzhi Shen,Xiaoyuan Zhang,Jiaping Tang,Zhixin Zhang,Renle Du,Dehong Luo,Xiaoran Liu,Yong Xia,Yanping Li,Shanshan Wang,Siyuan Yan,Wancai Yang,Rong Xiang,Na Luo,Yunping Luo,Jianjun Li

DOI: https://doi.org/10.7150/thno.62534

IF: 11.6

2021-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.51000.].

medicine, research & experimental
Correction To: Emerging Role of Lipid Metabolism Alterations in Cancer Stem Cells

Mei Yi,Junjun Li,Shengnan Chen,Jing Cai,Yuanyuan Ban,Qian Peng,Ying Zhou,Zhaoyang Zeng,Shuping Peng,Xiaoling Li,Wei Xiong,Guiyuan Li,Bo Xiang

DOI: https://doi.org/10.1186/s13046-018-0826-z

IF: 12.658

2018-01-01

Journal of Experimental & Clinical Cancer Research

Abstract:In the publication of this article [1], there is an error in the Figure caption of Figs. 2, 3 and 4. This has now been included in this correction. The authors declare that these corrections do not change the results or conclusions of this paper.
Correction: CSN6–TRIM21 axis instigates cancer stemness during tumorigenesis

Baifu Qin,Shaomin Zou,Kai Li,Huashe Wang,Wenxia Wei,Boyu Zhang,Lishi Xiao,Hyun Ho Choi,Qin Tang,Dandan Huang,Qingxin Liu,Qihao Pan,Manqi Meng,Lekun Fang,Mong-Hong Lee

DOI: https://doi.org/10.1038/s41416-020-0977-5

IF: 9.075

2020-07-09

British Journal of Cancer

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

oncology
Author Correction: PAK1 confers chemoresistance and poor outcome in non-small cell lung cancer via β-catenin-mediated stemness

Ming-Jenn Chen,De-Wei Wu,Yao-Chen Wang,Chi-Yi Chen,Huei Lee

DOI: https://doi.org/10.1038/s41598-020-74206-6

IF: 4.6

2020-10-23

Scientific Reports

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

multidisciplinary sciences
Corrigendum: Doxycycline Inhibits Cancer Stem Cell-Like Properties via PAR1/FAK/PI3K/AKT Pathway in Pancreatic Cancer

Huijuan Liu,Honglian Tao,Hongqi Wang,Yuyan Yang,Ru Yang,Xintong Dai,Xiujuan Ding,Haidong Wu,Shuang Chen,Tao Sun

DOI: https://doi.org/10.3389/fonc.2022.830506

IF: 4.7

2022-02-24

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.619317.].

oncology
Corrigendum: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma

Yicong Yao,Yi Wang,Denglong Wu,Baoying Hu

DOI: https://doi.org/10.3389/fonc.2021.731942

IF: 4.7

2021-07-21

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.666418.].

oncology
Correction: Clinical Significance and Effect of AEG-1 on the Proliferation, Invasion, and Migration of NSCLC: a Study Based on Immunohistochemistry, TCGA, Bioinformatics, in Vitro and in Vivo Verification.

Yu Zhang,Zu-Yun Li,Xin-Xi Hou,Xiao Wang,Yi-Huan Luo,Yan-Ping Ying,Gang Chen

DOI: https://doi.org/10.18632/oncotarget.28212

2022-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.14972.].
Author Correction to “Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy” [acta Pharm Sin B 12 (2022) 4224–4234]

Zekun Li,Yongchun Pan,Shizheng Du,Yayao Li,Chao Chen,Hongxiu Song,Yueyao Wu,Xiaowei Luan,Qiang Xu,Xiaoxiang Guan,Yujun Song,Xin Han

DOI: https://doi.org/10.1016/j.apsb.2023.09.002

IF: 14.903

2024-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.06.016.].
Erratum to “Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-κB Axis”

Chenglin Han,Zilong Wang,Shuxiao Chen,Lin Li,Yingkun Xu,Weiting Kang,Chunxiao Wei,Hongbin Ma,Muwen Wang,Xunbo Jin

DOI: https://doi.org/10.1155/2021/9857803

2021-12-14

Oxidative Medicine and Cellular Longevity

Abstract:[This corrects the article DOI: 10.1155/2021/8851763.].

cell biology
Corrigendum: Correction of the Figure. Identification of Adhesion-Associated Extracellular Matrix Component Thrombospondin 3 As a Prognostic Signature for Clear Cell Renal Cell Carcinoma.

Xiangling Chen,Jiatian Lin,Min Chen,Qiaoling Chen,Zhiming Cai,Aifa Tang

DOI: https://doi.org/10.4111/icu.20210273c

2023-01-01

Investigative and Clinical Urology

Abstract:This corrects the article on p. 107 in vol. 63, PMID: 34983129.
Corrigendum: LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma

Meng-Xia Zhang,Li Wang,Lei Zeng,Zi-Wei Tu

DOI: https://doi.org/10.3389/fonc.2021.670714

IF: 4.7

2021-03-18

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.605777.].

oncology
Erratum: Tertiary Lymphoid Structures Associate with Tumour Stage in Urothelial Bladder Cancer

Madhuri Koti,Amanda Shuo Xu,Kevin Yi Mi Ren,Kash Visram,Runhan Ren,David M Berman,D Robert Siemens

DOI: https://doi.org/10.3233/BLC-189029

2018-01-20

Bladder Cancer

Abstract:[This corrects the article DOI: 10.3233/BLC-170120.].
Corrigendum: Bioinformatics Analysis Reveals an Association Between Cancer Cell Stemness, Gene Mutations, and the Immune Microenvironment in Stomach Adenocarcinoma

Zaisheng Ye,Miao Zheng,Yi Zeng,Shenghong Wei,Yi Wang,Zhitao Lin,Chen Shu,Yunqing Xie,Qiuhong Zheng,Luchuan Chen

DOI: https://doi.org/10.3389/fgene.2022.828664

IF: 3.7

2022-02-14

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2020.595477.].

genetics & heredity
Corrigendum: Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis

Ganping Wang,Yarong Dai,Kang Li,Maosheng Cheng,Gan Xiong,Xiaochen Wang,Shuang Chen,Zhi Chen,Jianwen Chen,Xiuyun Xu,Rong-song Ling,Liang Peng,Demeng Chen

DOI: https://doi.org/10.3389/fcell.2021.675417

IF: 5.5

2021-03-24

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2021.627706.].

cell biology,developmental biology
Correction: An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+ Breast Cancer Cell Lines and Mouse Tumor Xenografts

Qing Chen,Ziyi Weng,Yunshu Lu,Yijun Jia,Longlong Ding,Fang Bai,Meixin Ge,Qing Lin,Kejin Wu

DOI: https://doi.org/10.1371/journal.pone.0311128

IF: 3.7

2024-09-23

PLoS ONE

Abstract:[This corrects the article DOI: 10.1371/journal.pone.0168960.].
Corrigendum: Autophagy Blockade by Ai Du Qing Formula Promotes Chemosensitivity of Breast Cancer Stem Cells Via GRP78/β-Catenin/ABCG2 Axis

Mianmian Liao,Caiwei Wang,Bowen Yang,Danping Huang,Yifeng Zheng,Shengqi Wang,Xuan Wang,Juping Zhang,Chunbian Tang,Zheng Xu,Yu He,Ruolin Huang,Fengxue Zhang,Zhiyu Wang,Neng Wang

DOI: https://doi.org/10.3389/fphar.2022.809565

IF: 5.6

2022-02-15

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.659297.].

pharmacology & pharmacy
Erratum: Author Correction to "Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy" [acta Pharm Sin B (2022) 4224-4234].

Zekun Li,Yongchun Pan,Shiyu Du,Yayao Li,Chao Chen,Hongxiu Song,Yueyao Wu,Xiaowei Luan,Qin Xu,Xiaoxiang Guan,Yujun Song,Xin Han

DOI: https://doi.org/10.1016/j.apsb.2023.09.002

IF: 14.903

2023-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.06.016.].

Correction To: CBFA2T2 is Associated with a Cancer Stem Cell State in Renal Cell Carcinoma

Correction: the Combination Effect of Homoharringtonine and Ibrutinib on FLT3-ITD Mutant Acute Myeloid Leukemia

CBFA2T2 is associated with a cancer stem cell state in renal cell carcinoma

Correction To: Cancer Biother Radiopharm 2017;32(3):101–110

CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis: Erratum

Correction To: Emerging Role of Lipid Metabolism Alterations in Cancer Stem Cells

Correction: CSN6–TRIM21 axis instigates cancer stemness during tumorigenesis

Author Correction: PAK1 confers chemoresistance and poor outcome in non-small cell lung cancer via β-catenin-mediated stemness

Corrigendum: Doxycycline Inhibits Cancer Stem Cell-Like Properties via PAR1/FAK/PI3K/AKT Pathway in Pancreatic Cancer

Corrigendum: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma

Correction: Clinical Significance and Effect of AEG-1 on the Proliferation, Invasion, and Migration of NSCLC: a Study Based on Immunohistochemistry, TCGA, Bioinformatics, in Vitro and in Vivo Verification.

Author Correction to “Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy” [acta Pharm Sin B 12 (2022) 4224–4234]

Erratum to “Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-κB Axis”

Corrigendum: Correction of the Figure. Identification of Adhesion-Associated Extracellular Matrix Component Thrombospondin 3 As a Prognostic Signature for Clear Cell Renal Cell Carcinoma.

Corrigendum: LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma

Erratum: Tertiary Lymphoid Structures Associate with Tumour Stage in Urothelial Bladder Cancer

Corrigendum: Bioinformatics Analysis Reveals an Association Between Cancer Cell Stemness, Gene Mutations, and the Immune Microenvironment in Stomach Adenocarcinoma

Corrigendum: Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis

Correction: An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+ Breast Cancer Cell Lines and Mouse Tumor Xenografts

Corrigendum: Autophagy Blockade by Ai Du Qing Formula Promotes Chemosensitivity of Breast Cancer Stem Cells Via GRP78/β-Catenin/ABCG2 Axis

Erratum: Author Correction to "Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy" [acta Pharm Sin B (2022) 4224-4234].